MAP2K5 and breast cancer: In particular, the silencing efficiency of lentiviral-MEK5-siRNA-3 was the highest, with the reduction of MEK5 mRNA expression by 86.3 % (P = 0.025) and protein expression by 69.6 % (Fig. 4) comparing with BC cells.